SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1946)2/26/1999 3:19:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
Forgive me for asking Steve, but is it possible that you could be wrong about the cash?



To: Steve Harmon who wrote (1946)2/26/1999 3:26:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
Did anybody else notice that shares outstanding increased to 24,317,020 from 22,983,687?



To: Steve Harmon who wrote (1946)2/26/1999 3:36:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
Did anybody else notice that earnings per share were up -- $(.006) vs. $(.009)?




To: Steve Harmon who wrote (1946)3/2/1999 6:15:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
Steve, how did you come up with $13- 14 million in cash and cash receivables? I looked at the 10Q and came up with $9 million. That could be rounded up to $10 million when you add the $750,000 that they will get from TECH. Does CIST have another $3 million payment coming from Immunex?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News